Presentation is loading. Please wait.

Presentation is loading. Please wait.

Purpose To clarify award close out policy, procedures, roles and responsibilities related to Sponsored Projects from the Pre-Award perspective.

Similar presentations


Presentation on theme: "Purpose To clarify award close out policy, procedures, roles and responsibilities related to Sponsored Projects from the Pre-Award perspective."— Presentation transcript:

1

2 Purpose To clarify award close out policy, procedures, roles and responsibilities related to Sponsored Projects from the Pre-Award perspective

3

4 Everyone Has a Role  SPAdmin  SPAcct  Principal Investigators  Departmental/Unit Administrator

5 What is the Role of SPAdmin?  Understanding and assisting in interpretation of Sponsor’s requirements Effects of these requirements on department/unit Restrictions/flexibility of SPAcct to meet spoonsor’s terms University policies and procedures related to close outs

6 What is the Role of SPAdmin?  Negotiating subagreements Out ○ Flowdown sponsor agreements ○ Ensure reports and deliverables are received on time In ○ Ensure project is not continuing without a contract in place ○ Ensure prime monitoring expectations are being met

7 What is the Role of SPAdmin?  Monitoring End dates Notify PIs and departmental/unit administrators of upcoming award expirations Clarify departmental needs and sponsor expecations ○ Extension ○ Advance Accounts ○ Close Outs

8 What is the Role of SPAdmin?  Reporting to Board of Regents Reconciling Revenue reported (Plans) to Revenue Received

9 Myths  Pre-award does not need to know when a grant/contract is closed out  If it’s not federal – begin and end dates don’t matter  No cost extensions are not required in industry sponsored agreements  We do not have to treat clinical trial contracts the same as grants  Advance accounts are not allowable on contracts  Residuals are allowable on non-federal projects  Receiving partial indirects is a justification for keeping greater than 25% residuals

10

11 Myth 1  Pre-award does not need to know when a grant/contract is closed out BOR reporting Sponsor reporting Terms/Conditions Advance accounts

12

13 Myth 2  If it’s not federal – begin and end dates don’t matter Consistency Liability Indemnification

14 Myth 3  No cost extensions are not required in industry sponsored agreements Consistency Contract specific

15 Myth 4  We do not have to treat clinical trial contracts the same as grants Maybe – maybe not

16 Extension Memos  Use one of the following  PI must sign  Provide information in red

17 Extension: No Sponsor Approval Required

18 Extension: Sponsor Approval Required

19

20 Myth 5  Advance accounts are not allowable on contracts IRB fees No IRB/IACUC/IBC approvals required Work separate from approvals being conducted

21 Advance Accounts Background  Assigned to a sponsored project before the award or extension process is completed Most common with subcontracts  Approval includes authorization to incur costs outside of the official project start and end dates  Are zero balance accounts Incur expenses No budget or revenue  35 & 36 WBS advance accounts will become account number  34 accounts will be assign as 37 WBS advance accounts

22 Advance Accounts Advance accounts might be appropriate if:  The project start date occurs before the award process has been completed  A contract extension is in negotiation and has yet to b signed by all parties  Extension of awards or subcontracts are delayed pending finalization by the sponsor or the federal government  Sponsor grants pre-spend authority

23 Advance Account Form

24

25

26 Myth 6  Residuals are allowable on non-federal projects Depends ○ Terms/Conditions Cost reimbursement vs. Fixed Price Guidelines Contracts

27 Myth 7  Receiving partial indirects is a justification for keeping greater than 25% residuals Consistency Anti-Kickback Pre-award consideration – not at close-out

28

29 Important Aspects of Revenue and Expense Summary for SPAdmin Revenue (over)/under expense Revenue Plan Life to Date Variance Total Expense Expenses

30 Revenue  Plan is information that is reported to Board of Regents (BOR) $100 million = Revenue not Plan  Big disconnects: Clinical Trial agreements ○ number of patients recruited  Adjustments need to be made, when Plan does not match Life to Date – to reflect actual funds received Plan = Amount of Award Checklists set up in SPAdmin Database Life to Date = Actual Funds Received *Note: Close outs should not be requested until all revenue is received from the Sponsor Variance = +/- the difference between Plan and Life to Date = the dollar figure that must be on the internal budget sent to SPAdmin for close out = Revenue Reported to BOR

31 Revenue Formulas  Example: 77,433/1.26 = 61,454.76 (Direct Costs) 77,433 – 61,454.76 = 15,978.24 (F&A Costs) * F&A rate Variance / 1.26* = Direct Costs Variance Direct Costs = F&A Costs

32 Close Out Budget Fields

33 Completed Close Out Budget Using the Example Provided in this Process Illustration

34 Close Out Memos  Use one of the following  PI must sign  Provide information in red

35 No Adjustments = 0 (No budget Needed) = (No Residual Funds) = 0 (No Residual Funds) Revenue (over)/under expense Variance Total Expense Life to Date

36 Close Out: No Adjustments

37 Adjustment/No Residuals > 0 (Budget Needed - ± for amount) = (No Residual Funds) = 0 (No Residual Funds) Revenue (over)/under expense Variance Total Expense Life to Date

38 Close Out: Adjustment with no Residuals

39 Adjustment/Residuals <25% > 0 (Budget Needed - ± for amount) ≠ (Residual Funds) ≠ 0 (Residual Funds) × 25% = 25% threshold < 25% threshold Revenue (over)/under expense Variance Total Expense Life to Date Revenue (over)/under expense Life to Date

40 Close Out: Adjustment with Residuals less than 25%

41 Adjustment/Residuals >25% > 0 (Budget Needed - ± for amount) ≠ (Residual Funds) ≠ 0 (Residual Funds) × 25% = 25% threshold > 25% threshold Provide justification Revenue (over)/under expense Variance Total Expense Life to Date Revenue (over)/under expense Life to Date

42 Close Out: Adjustment with Residuals Greater than 25%

43

44 Residual Justification? Anti-Kickback Act of 1986 - Compliance If there is significant residual fund balance, i.e., an amount greater than or equal to 25 percent of the contract/grant price, at the completion of work for the contract/grant, the Principal Investigator must provide a written explanation for the substantial discrepancy between the cost to perform the contract/grant and the contract/grant price. This explanation should be supplied by the Principal Investigator to Sponsored Programs Administration, which will use it along with the information that the Principal Investigator is required to provide upon closeout of the agreement as the basis for an audit of the project.

45 University Residual Policy Comparisons University of Idaho10% San Francisco State University$1,000 Georgia Southern University25% Texas A & M25% University of Pennsylvania Health System 50%

46 Return Residuals to Sponsor > 0 (Budget Needed - ± for amount) ≠ (Residual Funds) ≠ 0 (Residual Funds) Variance Total Expense Life to Date Revenue (over)/under expense

47 Close Out: Return Residuals To the Sponsor

48

49

50

51

52

53

54

55

56

57

58 Conclusion Timely project close out/extension action is critical to: Accurate revenue reporting to BOR Comply with internal and external policy Ensure receipt of final payment Save time, money and reputation of the institution Protect against withholding of new awards campus-wide by the awarding agency Prevent suspension of payments for costs incurred on other projects funded by the same agency

59 Policy References  A-21  A-133  A-110  Anti-Kickback Act of 1986 42 U.S.C. 1320a-7b(b)

60 Questions?


Download ppt "Purpose To clarify award close out policy, procedures, roles and responsibilities related to Sponsored Projects from the Pre-Award perspective."

Similar presentations


Ads by Google